News

News

FibroGen Receives Orphan Drug Designation from the U.S. FDA For Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy

FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics, today…

4/15/2019

FibroGen Reports Fourth Quarter and Full Year 2018 Financial Results

FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics, today…

2/27/2019

Connecture Announces The Sale Of Its Commercial U65 Business Unit to Benefitfocus

Connecture, Inc. announces the sales of its Commercial U65 business unit to Benefitfocus With the sale of the U65…

2/26/2019

Crossmatch Fingerprint Reader Provides Biometric Security for ThinkPad T490 Healthcare Edition

Crossmatch®, part of HID Global, today announced its fingerprint reading technology is enabling secure identity management on the newly revealed Lenovo ThinkPad T490 Healthcare Edition.…

2/12/2019